0001628280-24-023600.txt : 20240515
0001628280-24-023600.hdr.sgml : 20240515
20240515163457
ACCESSION NUMBER: 0001628280-24-023600
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240513
FILED AS OF DATE: 20240515
DATE AS OF CHANGE: 20240515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lewis William
CENTRAL INDEX KEY: 0001402051
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30739
FILM NUMBER: 24951856
MAIL ADDRESS:
STREET 1: 10 FINDERNE AVENUE
STREET 2: BUILDING 10
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSMED Inc
CENTRAL INDEX KEY: 0001104506
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 541972729
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 908-977-9900
MAIL ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: INSMED INC
DATE OF NAME CHANGE: 20000128
4
1
wk-form4_1715805282.xml
FORM 4
X0508
4
2024-05-13
0
0001104506
INSMED Inc
INSM
0001402051
Lewis William
700 US HIGHWAY 202/206
BRIDGEWATER
NJ
08807
1
1
0
0
Chair and CEO
0
Common Stock
2024-05-13
4
A
0
42707
A
406323
D
Common Stock
2024-05-14
4
S
0
22198
25.52
D
384125
D
Common Stock
233924
I
By ARTICLE 4 KATIE PROCTER DYNASTY TRUST
Common Stock
50500
I
By ARTICLE 4 UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020
Stock Option (right to buy)
25.83
2024-05-13
4
A
0
209320
0
A
2034-05-13
Common Stock
209320
209320
D
Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% percent on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
Each RSU was granted on May 13, 2024 for no consideration.
Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees.
This is the weighted average sales price representing 22,198 shares sold at prices ranging from $25.41 to $25.67 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the Initial Vesting Date.
/s/ William Lewis, by Michael A. Smith as Attorney-in-fact
2024-05-15